| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052022 Molecular cloning of a chemokine like 7TMR (AXOR87) |
| 05/02/2002 | US20020051819 Hexapeptide mixture with antimicrobial activity against Burkholderia cepacia and at least one carrier, effeactive for prevention of growth of Burkholderia cepacia for industrial, pharmeceutical, household and personal care use |
| 05/02/2002 | US20020051818 A core in the form of a tablet and having an enteric coating surrounding core, comprising an acid labile medicament, a binder or filler, a disintegrant and a lubricant, coating is formed of methacrylic acid copolymer and plasticizer |
| 05/02/2002 | US20020051793 Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051787 Steroids, viricides, and anti-microbial neutralizing antibodies suspended in a carrier |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051776 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051775 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051774 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/02/2002 | US20020051773 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051772 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 05/02/2002 | US20020051770 Virus neutralizing level of antibodies |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201765A2 Cellular kinases involved in cytomegalovirus infection and their inhibition |
| 05/02/2002 | EP1201678A1 Novel bicyclonucleoside analogues |
| 05/02/2002 | EP1201677A1 Novel macrolide compound jk |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201670A2 Process for preparing 2-oxaisocephem derivatives |
| 05/02/2002 | EP1201251A1 Stratified and cryogenically stored vaccines, process for their preparation |
| 05/02/2002 | EP1201239A1 Cyclic amine ccr3 antagonists |
| 05/02/2002 | EP1201237A1 Composition comprising an amide or a dialkylsulphoxide derivative for the treatment of cancer |
| 05/02/2002 | EP1201236A1 Medicinal compositions for preventing or treating viral myocarditis |
| 05/02/2002 | EP1201136A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200599A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200594A2 Protective antigen of epstein barr virus |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200580A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200468A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF i STAPHYLOCOCCUS AUREUS /i ELONGATION FACTOR P |
| 05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| 05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 05/02/2002 | EP1200462A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 05/02/2002 | EP1200461A2 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 05/02/2002 | EP1200460A1 Pseudomycin n-acyl side-chain analogs |
| 05/02/2002 | EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/02/2002 | EP1200457A2 Cysteine protease inhibitors |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200416A1 Oxazolidinones and their use as antiinfectives |
| 05/02/2002 | EP1200402A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 05/02/2002 | EP1200400A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200126A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
| 05/02/2002 | EP1200122A2 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 05/02/2002 | EP1200121A2 Fish vaccine |
| 05/02/2002 | EP1200120A1 Pneumococcal vaccines |
| 05/02/2002 | EP1200112A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/02/2002 | EP1200109A1 Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| 05/02/2002 | EP1200097A2 Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation |
| 05/02/2002 | EP1200096A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 05/02/2002 | EP1200094A1 Ophthalmic compositions containing antibiotics and nsaids |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200083A1 Antibiotic compound |
| 05/02/2002 | EP1200074A2 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes |
| 05/02/2002 | EP1200067A1 Delivery system for biological material |
| 05/02/2002 | EP1200065A1 Intravaginal clindamycin ovule composition |
| 05/02/2002 | EP1200064A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 05/02/2002 | EP1156791A4 Bupropion to treat viral diseases |
| 05/02/2002 | EP1089726B1 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
| 05/02/2002 | EP1076718B1 Novel method for preparing synthesis intermediates |
| 05/02/2002 | EP0975216A4 A method for treating papillomavirus infections |
| 05/02/2002 | EP0946579B1 Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 05/02/2002 | EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 05/02/2002 | EP0928192B1 Antimycotic gel with high active substance release |
| 05/02/2002 | EP0561883B1 Polymorphs of crystalline mupirocin |
| 05/02/2002 | DE10052322A1 Storage-stable solid chlorhexidine composition used for preparing aqueous disinfectant solutions e.g. for skin disinfection contains sugar acid and microbicidal quaternary ammonium bromide |
| 05/02/2002 | CA2678256A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2464228A1 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426360A1 Enhancers for microbiological disinfection and targeted apoptosis |
| 05/02/2002 | CA2425596A1 Methods of therapy for hiv infection |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | CA2422787A1 C-nitroso compounds and use thereof |
| 05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/01/2002 | CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
| 05/01/2002 | CN1347421A Antifungal agents isolated from pseudomonas syringae |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 05/01/2002 | CN1347417A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |